Article info
Hepatology
Original research
Bioinformatic analysis of RHO family of GTPases identifies RAC1 pharmacological inhibition as a new therapeutic strategy for hepatocellular carcinoma
- Correspondence to Prof Guillermo D Mazzolini, Gene Therapy Laboratory, Instituto de Investigaciones en Medicina Traslacional, Facultad de Ciencias Biomédicas, Universidad Austral, Derqui, Buenos Aires, Argentina; gmazzoli{at}austral.edu.ar
Citation
Bioinformatic analysis of RHO family of GTPases identifies RAC1 pharmacological inhibition as a new therapeutic strategy for hepatocellular carcinoma
Publication history
- Received April 15, 2020
- Revised August 15, 2020
- Accepted September 16, 2020
- First published October 26, 2020.
Online issue publication
June 07, 2021
Article Versions
- Previous version (26 October 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.